Study of the PAC-Man Model to Improve HIV Testing and Care for Mothers and Infants in Malawi
Led by University of North Carolina, Chapel Hill · Updated on 2025-09-26
2426
Participants Needed
3
Research Sites
N/A
Total Duration
AI-Summary
What this Trial Is About
Researchers are evaluating the PAC-Man model, an integrated differentiated services delivery DSD approach aimed at eliminating mother-to-child transmission of HIV in Malawi. This model combines three evidence-based practices pediatric active case finding using point-of-care early infant diagnosis technology, same-day antiretroviral therapy initiation for infants newly diagnosed with HIV, and maternal viral load testing with back-to-care services. The study uses a hybrid effectiveness-implementation stepped-wedge design involving 12 sites divided into clusters to compare the PAC-Man model with standard care.
The PAC-Man model is delivered through mobile care teams equipped with new diagnostic technology that brings services directly to the community, focusing on high-risk mother-infant pairs. The implementation strategy includes task shifting of testing and treatment duties to community health workers and changing service locations to more convenient community sites. Participants are randomly assigned by clusters to either receive the PAC-Man model alongside routine care or continue with standard Ministry of Health care.
Participants include mothers and infants enrolled in the national EMTCT program, healthcare workers, policymakers, and implementing partners, totaling over 2,400 individuals. The study measures outcomes such as the proportion of infants receiving early infant diagnosis testing by 6 months, maternal viral load testing adherence, infant ART initiation, viral suppression, and retention in care. Data is collected over 12 months following enrollment, and implementation outcomes like adoption rates and cost per pediatric case are also assessed.
CONDITIONS
Brief Title
Evaluation of a Differentiated Point-of-care Active Case Finding & Management Model to Eliminate Mother-to-Child Transmission of HIV in Malawi
Research Team
M
Michael Herce, MD, MPH
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborating Sponsor
Who Can Participate
Age: 16Years +
All Genders
Healthy Volunteers
Eligibility Criteria
You may qualify if you...
Enrolled in the national EMTCT program at a study site within the 12 months before a survey.
Age 16 years or older for field survey and in-depth interview participants.
Met high-risk criteria for PAC-Man model for in-depth interviews.
Professional or lay health worker at a study site, familiar with PAC-Man or EMTCT/EID services for focus groups and questionnaires.
HIV/EMTCT policy maker or senior manager familiar with service delivery for key informant interviews.
You will not qualify if you...
Documented transfer out from a study site before the field survey.
Previous participation in the field survey.
Declined informed consent for any study activity.
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Outpatient Treatment
Duration - Up to 12 months
Participants receive the PAC-Man model or standard care, which includes pediatric active case finding using point-of-care early infant diagnosis technology, same-day antiretroviral therapy initiation for infants diagnosed with HIV, and maternal viral load testing with back-to-care services. Services are delivered through mobile care teams in community settings under routine care.
Visits occur in the community as part of routine care; visit frequency may vary
Long-term Monitoring
Duration - Up to 12 months
Participants are monitored for infant HIV testing outcomes, ART initiation, viral suppression, and retention in care over 12 months following enrollment in the EMTCT program.
Assessments integrated with routine care visits up to 12 months post-enrollment
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Similar Trials
A Trauma-Informed Program to Increase HIV Prevention Medication Use Among Black Women in Baltimore
Testing a Behavioral Therapy to Improve HIV Prevention and Reduce Drug Use in Sexual Minority Adults Aged 18 to 34
Study of the MEPS Intervention for HIV and Substance Use Prevention in Recently Incarcerated Men Using Smartphones
DatAIDS Prevention Study on HIV and STI Screening and Prevention in France for Adults
Reducing Heavy Drinking and Improving HIV Prevention and Treatment Among Adults Receiving STI Care in Lilongwe, Malawi
Testing a Community-Based Long-Acting Injectable PrEP Program with Lenacapavir for HIV Prevention among Latine Gay, Bisexual Men, and Transgender Women in the South
Testing a Digital PrEP Toolkit to Help Cisgender Women in Alabama and Mississippi Learn About and Start HIV Prevention Medication
Study of the PAC-Man Model to Improve HIV Testing and Care for Mothers and Infants in Malawi
Study of Mobile Interventions to Reduce HIV Stigma and Increase PrEP Use Among Transgender Women in Thailand
Study of a Single Double Dose of FTAF Tablets to Understand Drug Levels in Healthy Adults for HIV Prevention
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Study design and procedures for a hybrid effectiveness-implementation incomplete stepped-wedge cluster-randomized trial to evaluate a differentiated point-of-care HIV diagnosis and management model for the prevention of vertical transmission of HIV in Malawi: The PAC-Man trial protocol.
Michael E Herce, Caitlin Cassidy, Alexandra Munson...